TY - JOUR
T1 - Development of a peer-review framework for cancer multidisciplinary meetings
AU - Johnson, Claire E.
AU - Slavova-Azmanova, Neli
AU - Saunders, Christobel
PY - 2017/5/14
Y1 - 2017/5/14
N2 - Background: There is no mechanism in place for monitoring or quality improvement of cancer multidisciplinary meetings (MDM) in Australia. Aim: To develop a peer-review process for quality improvement of MDM. Methods: This project involved three phases: (i) development of a draft peer-review framework, supporting documents and peer-review process; (ii) consultation with key stakeholders; (iii) refinement of the framework, documents and processes following a pilot study with three MDM. Results: Feedback indicated that specific standards included in the framework needed to allow the peer reviewers to be flexible relative to the circumstances of the individual MDM. Conversely, feedback identified the need for clear, evidence-based clinical practice guidelines for the conduct of MDM, with accepted standards and objective measures of performance. MDM members were divided about the need to employ peer reviewers from the tumour stream of the MDM under review but agreed that closer involvement of the team under review to support the implementation of recommendations is warranted. Conclusions: We developed an adaptable peer-review framework and process using the current available evidence and guidance. While further research is needed to establish what constitutes best practice in MDM and which processes contribute to improved patient outcomes, the structured peer-review process we describe, when modified using the disease-relevant evidence, could be utilised more broadly as a quality improvement tool.
AB - Background: There is no mechanism in place for monitoring or quality improvement of cancer multidisciplinary meetings (MDM) in Australia. Aim: To develop a peer-review process for quality improvement of MDM. Methods: This project involved three phases: (i) development of a draft peer-review framework, supporting documents and peer-review process; (ii) consultation with key stakeholders; (iii) refinement of the framework, documents and processes following a pilot study with three MDM. Results: Feedback indicated that specific standards included in the framework needed to allow the peer reviewers to be flexible relative to the circumstances of the individual MDM. Conversely, feedback identified the need for clear, evidence-based clinical practice guidelines for the conduct of MDM, with accepted standards and objective measures of performance. MDM members were divided about the need to employ peer reviewers from the tumour stream of the MDM under review but agreed that closer involvement of the team under review to support the implementation of recommendations is warranted. Conclusions: We developed an adaptable peer-review framework and process using the current available evidence and guidance. While further research is needed to establish what constitutes best practice in MDM and which processes contribute to improved patient outcomes, the structured peer-review process we describe, when modified using the disease-relevant evidence, could be utilised more broadly as a quality improvement tool.
KW - accreditation
KW - multidisciplinary cancer care
KW - multidisciplinary team meetings
KW - peer review
KW - quality improvement
UR - http://www.scopus.com/inward/record.url?scp=85019259201&partnerID=8YFLogxK
U2 - 10.1111/imj.13374
DO - 10.1111/imj.13374
M3 - Article
C2 - 28105750
AN - SCOPUS:85019259201
SN - 1444-0903
VL - 47
SP - 529
EP - 535
JO - Internal Medicine Journal
JF - Internal Medicine Journal
IS - 5
ER -